Gillespie, Stephen.
Tuberculosis new treatments in evolution / [electronic resource] : Stephen H. Gillespie. - London : Henry Stewart Talks, 2014. - 1 online resource (1 streaming video file (38 min.) : color, sound). - Respiratory infection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Respiratory infection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Tuberculosis history -- The streptomycin trial -- Headlines in tuberculosis drug development -- Standard treatment for drug-sensitive TB -- Toxicity -- Treatment duration -- Challenges in TB treatment -- Some examples of drugs in development -- New trials to shorten treatment for TB -- Fluoroquinolones for TB -- Johns Hopkins study -- REMoxTB study objective -- Overview of TB microbiology protocols -- Safety -- Gatifloxacin project: phase III -- More TB drug development approaches -- New combination regimen studies -- MAM- multi arm multi stage -- Developing new treatments for MDR/XDRTB -- Current WHO treatment for MDRTB -- Using existing and repurposed drugs -- New drugs for MDRTB (Delanamid, Bedaquinline) -- Drugs in development for MDR indication.
Access restricted to subscribers.
Mode of access: World Wide Web.
3631 Henry Stewart Talks
Antitubercular agents.
Drug development.
Tuberculosis--Chemotherapy.
Antitubercular Agents--therapeutic use.
Clinical Trials as Topic.
Drug Discovery--methods.
Tuberculosis--drug therapy.
Tuberculosis--microbiology.
Tuberculosis new treatments in evolution / [electronic resource] : Stephen H. Gillespie. - London : Henry Stewart Talks, 2014. - 1 online resource (1 streaming video file (38 min.) : color, sound). - Respiratory infection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Respiratory infection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Tuberculosis history -- The streptomycin trial -- Headlines in tuberculosis drug development -- Standard treatment for drug-sensitive TB -- Toxicity -- Treatment duration -- Challenges in TB treatment -- Some examples of drugs in development -- New trials to shorten treatment for TB -- Fluoroquinolones for TB -- Johns Hopkins study -- REMoxTB study objective -- Overview of TB microbiology protocols -- Safety -- Gatifloxacin project: phase III -- More TB drug development approaches -- New combination regimen studies -- MAM- multi arm multi stage -- Developing new treatments for MDR/XDRTB -- Current WHO treatment for MDRTB -- Using existing and repurposed drugs -- New drugs for MDRTB (Delanamid, Bedaquinline) -- Drugs in development for MDR indication.
Access restricted to subscribers.
Mode of access: World Wide Web.
3631 Henry Stewart Talks
Antitubercular agents.
Drug development.
Tuberculosis--Chemotherapy.
Antitubercular Agents--therapeutic use.
Clinical Trials as Topic.
Drug Discovery--methods.
Tuberculosis--drug therapy.
Tuberculosis--microbiology.